Drugs firm Roche lines up new directors

Swiss drugs firm Roche today said Nestlé chief Paul Bulcke, Lufthansa head Christoph Franz and Royal Dutch Shell boss Peter Voser will stand for election to its board of directors next year.

The group also said Walter Frey, who has been on the board since 2001, and Wolfgang Ruttenstorfer, a board member since 2007, will not run for re-election.

Bruno Gehrig, Pius Baschera, Lodewijk de Vink and Andreas Oeri will be proposed for a further period of office, Roche said, and added that the board will also propose that the term of office of board members be reduced to two years from three years.